Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC. Reply.

Journal

The New England journal of medicine

Journal Volume

394

Journal Issue

9

Start Page

935

End Page

936

ISSN

1533-4406

Date Issued

2026-02-26

Author(s)

Sethi, Seema

Cho, Byoung Chul

DOI

10.1056/NEJMc2517120

URI

https://scholars.lib.ntu.edu.tw/handle/123456789/737757

Type

letter